Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413061 | 12741306 | 1 | I | 20100505 | 20150710 | 20160914 | 20160914 | EXP | US-ROCHE-1670321 | ROCHE | 56.00 | YR | F | Y | 48.00000 | KG | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127413061 | 12741306 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 1 | U | 125085 | 1100 | MG | |||||||
| 127413061 | 12741306 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 2 | U | 125085 | 1100 | MG | |||||||
| 127413061 | 12741306 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 3 | U | 125085 | 1100 | MG | |||||||
| 127413061 | 12741306 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 4 | U | 125085 | 1100 | MG | |||||||
| 127413061 | 12741306 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 5 | U | 125085 | 500 | MG | |||||||
| 127413061 | 12741306 | 6 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 6 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 7 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 7 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 8 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 8 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 9 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 9 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 10 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 10 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 11 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 11 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | IV OVER 30 - 90 MIN ON DAYS 1 AND 15?COURSE ID: 12 | U | 125085 | 1000 | MG | |||||||
| 127413061 | 12741306 | 13 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE: 1 | Y | U | 0 | 100 | MG | ||||||
| 127413061 | 12741306 | 14 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 2 | Y | U | 0 | 100 | MG | ||||||
| 127413061 | 12741306 | 15 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 3 | Y | U | 0 | 100 | MG | ||||||
| 127413061 | 12741306 | 16 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 4 | Y | U | 0 | 80 | MG | ||||||
| 127413061 | 12741306 | 17 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 5 | Y | U | 0 | 60 | MG | ||||||
| 127413061 | 12741306 | 18 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 6 | Y | U | 0 | 60 | MG | ||||||
| 127413061 | 12741306 | 19 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 7 | Y | U | 0 | 60 | MG | ||||||
| 127413061 | 12741306 | 20 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 8 | Y | U | 0 | 45 | MG | ||||||
| 127413061 | 12741306 | 21 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 9 | Y | U | 0 | 45 | MG | ||||||
| 127413061 | 12741306 | 22 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 10 | Y | U | 0 | 45 | MG | ||||||
| 127413061 | 12741306 | 23 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 11 | Y | U | 0 | 45 | MG | ||||||
| 127413061 | 12741306 | 24 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | IV ON DAYS 1, 8, 15, 22?COURSE ID: 12 | Y | U | 0 | 60 | MG | ||||||
| 127413061 | 12741306 | 25 | SS | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 127413061 | 12741306 | 26 | SS | NOVOLOG | INSULIN ASPART | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127413061 | 12741306 | 1 | Pancreatic neuroendocrine tumour metastatic |
| 127413061 | 12741306 | 2 | Endometrial cancer |
| 127413061 | 12741306 | 3 | Ovarian cancer |
| 127413061 | 12741306 | 4 | Hepatocellular carcinoma |
| 127413061 | 12741306 | 5 | Malignant neoplasm of islets of Langerhans |
| 127413061 | 12741306 | 13 | Pancreatic neuroendocrine tumour metastatic |
| 127413061 | 12741306 | 14 | Endometrial cancer |
| 127413061 | 12741306 | 15 | Ovarian cancer |
| 127413061 | 12741306 | 16 | Hepatocellular carcinoma |
| 127413061 | 12741306 | 17 | Malignant neoplasm of islets of Langerhans |
| 127413061 | 12741306 | 25 | Product used for unknown indication |
| 127413061 | 12741306 | 26 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127413061 | 12741306 | OT |
| 127413061 | 12741306 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127413061 | 12741306 | Aspartate aminotransferase increased | |
| 127413061 | 12741306 | Blood alkaline phosphatase increased | |
| 127413061 | 12741306 | Hyperglycaemia | |
| 127413061 | 12741306 | Hypoglycaemia | |
| 127413061 | 12741306 | Hyponatraemia | |
| 127413061 | 12741306 | Neutrophil count decreased | |
| 127413061 | 12741306 | Pulmonary haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127413061 | 12741306 | 1 | 20091223 | 0 | ||
| 127413061 | 12741306 | 2 | 20100120 | 0 | ||
| 127413061 | 12741306 | 3 | 20100217 | 0 | ||
| 127413061 | 12741306 | 4 | 20100317 | 0 | ||
| 127413061 | 12741306 | 5 | 20100421 | 0 | ||
| 127413061 | 12741306 | 6 | 20100519 | 0 | ||
| 127413061 | 12741306 | 7 | 20100616 | 0 | ||
| 127413061 | 12741306 | 8 | 20100714 | 0 | ||
| 127413061 | 12741306 | 9 | 20100811 | 0 | ||
| 127413061 | 12741306 | 10 | 20100915 | 0 | ||
| 127413061 | 12741306 | 11 | 20101013 | 0 | ||
| 127413061 | 12741306 | 12 | 20101110 | 0 | ||
| 127413061 | 12741306 | 13 | 20091223 | 0 | ||
| 127413061 | 12741306 | 14 | 20100120 | 0 | ||
| 127413061 | 12741306 | 15 | 20100217 | 0 | ||
| 127413061 | 12741306 | 16 | 20100317 | 0 | ||
| 127413061 | 12741306 | 17 | 20100421 | 0 | ||
| 127413061 | 12741306 | 18 | 20100519 | 0 | ||
| 127413061 | 12741306 | 19 | 20100616 | 0 | ||
| 127413061 | 12741306 | 20 | 20100714 | 0 | ||
| 127413061 | 12741306 | 21 | 20100811 | 0 | ||
| 127413061 | 12741306 | 22 | 20100915 | 0 | ||
| 127413061 | 12741306 | 23 | 20101013 | 0 | ||
| 127413061 | 12741306 | 24 | 20101110 | 0 |